ACSM3 suppresses the pathogenesis of high-grade serous ovarian carcinoma via promoting AMPK activity

ConclusionOur data indicate that the ACSM3-AMPK axis is involved in the pathogenesis of HGSOC and, as such, may act as a therapeutic target for this cancer.

Source: Cellular Oncology - February 6, 2022 Category: Cancer & Oncology Source Type: research